News - Paul Ridker
Study highlights: -- People at intermediate risk of cardiovascular disease who have high levels of high sensitivity C-reactive protein (hsCRP), a blood marker for inflammation, could benefit from cholesterol-lowering therapy even if their cholesterol is already at desirable levels. -- Data indicates that people with only a 5 percent to 20 percent risk of having heart disease in the next ten years, but who have high levels of hsCRP could reduce the risk of heart attack and stroke by more than 40 percent. DALLAS, Aug.
Statin drugs, used by millions to reduce cholesterol levels and avoid heart disease, can reduce the possibility of blood clots that can form in the legs or lungs, a huge study announced on Sunday.
The idea that lowering cholesterol is the key to preventing heart attacks and cardiovascular disease has taken a couple of big hits recently. The first came on Mar.
The idea that lowering cholesterol is the key to preventing heart attacks and cardiovascular disease has taken a couple of big hits recently.
By ED SUSMAN New studies suggest that changing the timing for measuring blood fats may provide better information about future heart disease risk -- the test might be more accurate if the patient being tested has had a meal.
